Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., is a specialty pharmaceutical company founded in 2019. The company operates within the industries of Health Care, Health and Wellness, and Pharmaceuticals. Adlon Therapeutics is dedicated to providing treatment options for patients suffering from symptoms of Attention Deficit/Hyperactivity Disorder (ADHD). Their mission revolves around developing innovative medicines and promoting responsible prescription stimulant utilization through awareness, research, and policies aligned with the appropriate diagnosis and treatment of ADHD. For further information, please visit www.adlontherapeutics.com.
There is no investment information
No recent news or press coverage available for Adlon Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
